Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Daniel, Serin"'
Autor:
Elie Rassy, Thomas Filleron, Alessandro Viansone, Magali Lacroix-Triki, Sofia Rivera, Isabelle Desmoulins, Daniel Serin, Jean Luc Canon, Mario Campone, Anthony Gonçalves, Christelle Levy, Paul Cottu, Thierry Petit, Jean-Christophe Eymard, Marc Debled, Thomas Bachelot, Florence Dalenc, Lise Roca, Jerôme Lemonnier, Suzette Delaloge, Barbara Pistilli
Publikováno v:
Breast Cancer Research and Treatment. 199:371-379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92b951a41b573f224f014c9e26e8e994
https://doi.org/10.1007/s10549-023-06912-4
https://doi.org/10.1007/s10549-023-06912-4
Publikováno v:
Bulletin du Cancer. 109:1029-1039
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4294a355a001ff01b49afe955363ed87
https://doi.org/10.1016/j.bulcan.2022.05.008
https://doi.org/10.1016/j.bulcan.2022.05.008
Publikováno v:
Oncologie. 24:25-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9066f6a5d49c409e32db3d7407a7ae3
https://doi.org/10.32604/oncologie.2022.018110
https://doi.org/10.32604/oncologie.2022.018110
Autor:
Olivia Pérol, Nadège Lepage, Hugo Noelle, Pierre Lebailly, Benoit de Labrusse, Bénédicte Clin, Mathilde Boulanger, Delphine Praud, Françoise Fournié, Géraud Galvaing, Frédéric Dutheil, Brigitte Le Meur, Daniel Serin, Eric Dansin, Catherine Nisse, Barbara Charbotel, Beatrice Fervers
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, 2023, 20 (6), pp.5068. ⟨10.3390/ijerph20065068⟩
International Journal of Environmental Research and Public Health; Volume 20; Issue 6; Pages: 5068
International Journal of Environmental Research and Public Health, 2023, 20 (6), pp.5068. ⟨10.3390/ijerph20065068⟩
International Journal of Environmental Research and Public Health; Volume 20; Issue 6; Pages: 5068
Occupational lung cancer cases remain largely under-reported and under-compensated worldwide. In order to improve the detection and compensation of work-related lung cancers, we implemented a systematic screening of occupational exposures, combining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4984935d00db8f6e74f913cdc1c9253e
https://doi.org/10.3390/ijerph20065068
https://doi.org/10.3390/ijerph20065068
Publikováno v:
Bulletin du cancer. 109(10)
In 2019, only 1,790 occupational cancers were recognized, i.e., less than 1% of estimated occupational cancers. Our study aims to expand the methodology of a French cancer center to improve the detection and compensation of occupational bronchopulmon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::418c57b336782f3f5e71981007b5fbdb
https://pubmed.ncbi.nlm.nih.gov/35995613
https://pubmed.ncbi.nlm.nih.gov/35995613
Autor:
Daniel Serin
Publikováno v:
Oncologie. 24:1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b38ee72311d9cf56145c37a28a47c71
https://doi.org/10.32604/oncologie.2022.020553
https://doi.org/10.32604/oncologie.2022.020553
Autor:
Stéphanie Catala, Laetitia Gambotti, C. Faure Mercier, L. Venat-Bouvet, Xavier Pivot, Sophie Paget-Bailly, Iris Pauporté, J-M Grouin, Christelle Jouannaud, J-Y Pierga, Julie Henriques, Maria Rios, David Khayat, Gilles Romieu, P. Kerbrat, Thomas Bachelot, P. Fumoleau, Daniel Serin, Marc Espié, Marc Debled, Sophie Abadie-Lacourtoisie, J.P. Jacquin, Alain Lortholary, L. Cany
Publikováno v:
Cancer Research. 79:GS2-07
Since 2005, 12 months of trastuzumab added to chemotherapy alone is the standard of care in patients with HER2-positive breast cancer. PHARE ('Protocol for Herceptin® as Adjuvant therapy with Reduced Exposure') is the first trial comparing a reducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a35c5957773bd793c5b7ce60ec226e39
https://doi.org/10.1158/1538-7445.sabcs18-gs2-07
https://doi.org/10.1158/1538-7445.sabcs18-gs2-07
Autor:
J. Coussirou, M. Valéro, S. Alran, G. Ninot, S. Adnot, A. Lesur, M.K. Bendiane, Cécile Charles, J. Neveu, A. Clément, J.-J. Zambrowski, Daniel Serin, C. Ledig, Marie Préau, L. Degos, T. Durand, C. Allioux, B. Bazin, B. Favier, C. Rousset-Jablonski, Julien Mancini, Pierre-Etienne Heudel, J. Moretta, Diane Boinon, P. Duponchel, A.D. Bouhnik, A. Monet, Sarah Dauchy, Bruno Cutuli, E. Bo-Gallon, Philippe Debourdeau, C. Ravot, Rajae Touzani, E. Bourstyn, François Eisinger, Claire Falandry
Publikováno v:
Oncologie. 20:145-189
Les 40es Journées de la SFSPM se sont tenues à Avignon du 7 au 9 novembre 2018. Le thème abordé—Cancer du sein : optimisation du parcours de soins — a réuni plus de 1 200 participants sous les voûtes du Palais des Papes. La fluidité de cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ab682b4191548ba2a4976b368ed23ee
https://doi.org/10.3166/onco-2019-0040
https://doi.org/10.3166/onco-2019-0040
Autor:
M. Campone, A. Gonçalves, L. Roca, A Zingarello, Sofia Rivera, H. Roche, Bruno Coudert, J-C Eymard, S Delaloge, Chafika Mazouni, Jérôme Lemonnier, J-L Canon, C. Tunon de Lara, Thomas Bachelot, Magali Lacroix-Triki, PH Cottu, Thomas Filleron, Daniel Serin, Christine Levy, Barbara Pistilli, Thierry Petit
Publikováno v:
Cancer Research. 78:P1-07
Purpose:Incidence of LRs in patients (pts) treated for HR+ HER2- localized BC and distribution overtime have not been described in recent years after introduction of new generation of adjuvant therapies and more extensive use of radiotherapy. We eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35c0f48a2fcb786ca3c00dba8c8597f
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-07
https://doi.org/10.1158/1538-7445.sabcs17-p1-07-07
Autor:
Maria Rios, Daniel Serin, Etienne Brain, Marie-Josèphe Foucher-Goudier, Henri Roché, Magali Edel, Thomas Bachelot, Mario Campone, Lise Roca, Pierre Kerbrat, Alain Marre, Alain Lortholary, Christelle Levy, Marc Debled, Patrice Viens, Jérôme Lemonnier, Isabelle Desmoulins, Marie-Ange Mourret-Reynier, Remy Delva, Bernard Asselain, Anne-Laure Martin
Publikováno v:
European Journal of Cancer. 79:166-175
Purpose Optimal duration of adjuvant chemotherapy in the treatment of early-stage breast cancer remained to be investigated rigorously for the standard regimens in widespread use in North America (doxorubicin/cyclophosphamide, AC) and Europe (5-fluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff7c5399b590d4cb2d0f9c065cc3e9a
https://doi.org/10.1016/j.ejca.2017.03.004
https://doi.org/10.1016/j.ejca.2017.03.004